Back
Results - Announcements
Bandaram Pharma Packtech Ltd consolidated sales down 8.80% on year in Q2FY2026, net profit saw a strong growth of 655.56%
13-Aug-2026, 10:25
Bandaram Pharma Packtech Ltd share price slipped 1.42% to Rs 18.69 after the company's net profit surged by 655.56% to Rs 0.68 crore, while revenue from operations eased by 8.80% to Rs 23.95 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 73454.32 crore, rising 9.56%. It has inched up 2.51% over last one week and surged by 15.08% in last one month while the market capitalization of Bandaram Pharma Packtech Ltd has softened by 4.19% and 33.63% in the same period respectively. Profit before tax (PBT) of Bandaram Pharma Packtech Ltd stood at Rs 0.92 crore in Q2 FY26, jumping 2200.00% year-on-year, and expanding by 666.67% quarter-on-quarter. EBITDA came in at Rs 2 crore, rallying 144.44% YoY and surging by 90.12% sequentially. Total expenses contracted by 11.99% to Rs 22.61 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 21.61 crore, slightly declining by 8.55% YoY, while employee benefits expense was at Rs 0.73 crore, tanking by 67.56% YoY. For the TTM ended FY26, revenue from operations posted a slight growth of 8.45% to Rs 36.96 crore, while net profit saw a marginal increase of 4.21% to Rs 0.99 crore, compared to previous TTM. EBITDA jumped by 205% to Rs 2.73 crore, and PBT improved 10.92% to Rs 1.32 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 4.93 crore in FY26, as against Rs 4.13 crore in FY25. Bandaram Pharma Packtech Ltd tumbled by 50.65% in last one year, underperforming the benchmark BSE Sensex which has eased by 2.83% during the same period.
Bandaram Pharma Packtech Ltd share price slipped 1.42% to Rs 18.69 after the company's net profit surged by 655.56% to Rs 0.68 crore, while revenue from operations eased by 8.80% to Rs 23.95 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 73454.32 crore, rising 9.56%. It has inched up 2.51% over last one week and surged by 15.08% in last one month while the market capitalization of Bandaram Pharma Packtech Ltd has softened by 4.19% and 33.63% in the same period respectively. Profit before tax (PBT) of Bandaram Pharma Packtech Ltd stood at Rs 0.92 crore in Q2 FY26, jumping 2200.00% year-on-year, and expanding by 666.67% quarter-on-quarter. EBITDA came in at Rs 2 crore, rallying 144.44% YoY and surging by 90.12% sequentially. Total expenses contracted by 11.99% to Rs 22.61 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 21.61 crore, slightly declining by 8.55% YoY, while employee benefits expense was at Rs 0.73 crore, tanking by 67.56% YoY. For the TTM ended FY26, revenue from operations posted a slight growth of 8.45% to Rs 36.96 crore, while net profit saw a marginal increase of 4.21% to Rs 0.99 crore, compared to previous TTM. EBITDA jumped by 205% to Rs 2.73 crore, and PBT improved 10.92% to Rs 1.32 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 4.93 crore in FY26, as against Rs 4.13 crore in FY25. Bandaram Pharma Packtech Ltd tumbled by 50.65% in last one year, underperforming the benchmark BSE Sensex which has eased by 2.83% during the same period.